MedTrace Logo

The Effects of Gonadotropin Replacement Therapy in Patients With Hypogonadism

NCT02042638 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2014-01-23

No results posted yet for this study

Summary

Effects of hCG replacement therapy on metabolic syndrome parameters in hypogonadotrophic hypogonadism.

Conditions

  • Idiopathic Hypogonadotropic Hypogonadism

Interventions

DRUG

hCG 1500 IU three times a week

DRUG

Pregnyl (hCG) ampule 1500 IU/three times a week

Sponsors & Collaborators

  • Gulhane School of Medicine

    lead OTHER

Principal Investigators

  • Fahri Bayram, Proffesor · Erciyes University School of Medicine Depatment of Endocrinology and Metabolism Kayseri TURKEY

Eligibility

Min Age
16 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02042638 on ClinicalTrials.gov